Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diethyl Ether | HCID 3283 | — |
| Reactant | Butylurea | HCID 11595 | — |
| Reactant | Potassium bisulfate | HCID 516920 | — |
| Reactant | Aluminium lithium hydride | HCID 21226445 | — |
| Solvent | Water | HCID 962 | — |
| Product | 1,4-Dibutylimidazol-2-one | HCID 15405728 | — |
Reaction Steps
Under nitrogen, a stirred solution of 10.0 g (36.5 mmol) of N-t-Boc-L-norleucine-N-methoxy-N-methylamide from Step 2 in 100 mL of methylene chloride at 0° C. was treated with 100 mL of trifluoroacetic acid (TFA). The reaction was allowed to warm to ambient temperature and stir. After 2 h, the reaction was concentrated in vacuo to give the TFA salt of L-norleucine-N-methoxy-N-methylamide as a viscous colorless oil: NMR (CDCl3) δ0.88 (t, J=7 Hz, 3H), 1.30-1.40 (m, 4H), 1.88 (t, J=7 Hz, 2H), 3.25 (s, 3H), 3.75 (s, 3H), 4.35-4.46 (m, 1H), 7.55-7.76 (br s, 3H). Under nitrogen, the TFA salt was dissolved in 150 mL of chloroform at 0° C. and sequentially treated with 7.37 g (73 mmol) of triethylamine and 5.42 g (55 mmol) of butyl isocyanate. The reaction was allowed to warm to ambient temperature and stir overnight; concentration in vacuo provided the crude product. Purification by silica gel chromatography (Waters Prep-500A) using ethyl acetate gave 9.0 g (90% from N-t-Boc-L-norleucine-N-methoxy-N-methylamide) of the N-butylurea of L-norleucine-N-methoxy-N-methylamide as a colorless oil: NMR (CDCl3) δ0.83-0.95 (m, 6H), 1.25-1.47 (m, 8H), 1.48-1.60 (m, 1H), 1.63-1.75 (m, 1H), 3.02-3.26 (m, 2H), 3.21 (s, 3H), 3.84 (s, 3H), 4.82-4.93 (m, 1H). Under nitrogen, a 9.0 g (32.5 mmol) sample of the urea was dissolved in 150 mL of anhydrous diethyl ether; the solution was cooled to 0° C. and slowly treated with 41 mL (41 mmol, 1.25 equiv) of a 1.0 M solution of lithium aluminum hydride (LAH) in ether. The reaction was allowed to warm to ambient temperature and stir overnight. A solution of 7.87 g (58 mmol) of potassium bisulfate in 165 mL of water was added cautiously and the reaction stirred for 4 h. The reaction mixture was transferred to a separatory funnel and the phases separated. The aqueous phase was extracted 3 times with additional ether. The combined ether extracts were washed 3 times each with 3N hydrochloric acid, saturated sodium bicarbonate, and brine. The ether extracts were then dried (MgSO4) and concentrated in vacuo to give 5.40 (85%) of 3,5-dibutylimidazol-2-one as a viscous colorless oil which solidified on storage in the refrigerator: NMR (CDCl3) δ0.91 (t,=7 Hz, 3H), 0.93 (t, J=7 Hz, 3H), 1.28-1.41 (m, 4H), 1.47-1.65 (m, 4H), 2.36 (td, J=7 and 1 Hz, 2H), 3.55 (t, J=7 Hz, 2H), 5.84 (t, J=1 Hz, 1H), 9.78 (br s, 1H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05238952 |
|---|
| Source dataset | uspto-grants-1993_08 |
|---|
| ORD ID | ord-5bb4baa5e5b6428d882f6cc2f74b3b5e |
|---|
| Source note | uspto-grants-1993_08 |
|---|